Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05124912 · ClinicalTrials.gov registry record · NA
REMASTer: REcurrent Brain Metastases After SRS Trial
A NA study of Brain Metastases and Radiation Necrosis, sponsored by Monteris Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 261
- Enrollment target
- 9
- Study locations
NCT05124912 is a NA study of Brain Metastases and Radiation Necrosis that is actively recruiting participants, run by Monteris Medical. The registered enrollment target is 261 participants, above the 209-participant average among 67 other Brain Metastases trials with a reported enrollment target (25% higher). The trial reports 9 study locations across 7 states.
The verdict
NCT05124912, a NA study of Brain Metastases and Radiation Necrosis, is actively recruiting participants, sponsored by Monteris Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 261 participants
- Enrollment target
- 9
- Study locations
Study Summary
Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
Conditions Studied
Interventions
- DRUG Steroid Therapy
- PROCEDURE Radiation Therapy
- PROCEDURE Laser Interstitial Thermal Therapy
Study Locations (9)
North Carolina
- Duke University Hospital - Durham
- Wake Forest Baptist Medical Center - Winston-Salem
Ohio
- Cleveland Clinic - Cleveland
- Kettering Health - Kettering
California
- UCLA - Los Angeles
Illinois
- University of Chicago - Chicago
Maryland
- University of Maryland - Baltimore
Missouri
- WashU - St Louis
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2022-05-10 |
| Est. Completion | 2028-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05124912
The ClinicalTrials.gov registry entry for NCT05124912 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 261 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 209-participant average among 67 other Brain Metastases trials with a reported enrollment target (25% higher). The listed sponsor is Monteris Medical, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Brain Metastases appearing as the primary indexed condition, and to 3 interventions - of which Steroid Therapy is the first listed.
NCT05124912 reports 9 study locations spanning 7 distinct geographic areas - top geographies include North Carolina, Ohio, California.
Frequently Asked Questions
What is clinical trial NCT05124912 about?
NCT05124912 is a clinical study titled "REMASTer: REcurrent Brain Metastases After SRS Trial". Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
What is the current status of trial NCT05124912?
This trial is currently recruiting. It is a NA study. The enrollment target is 261 participants. The study started on 2022-05-10. Estimated completion is 2028-10.
What conditions does trial NCT05124912 study?
This clinical trial studies the following conditions: Brain Metastases, Radiation Necrosis, Recurrent Tumor, Recurrent Metastases.
What interventions are being tested in trial NCT05124912?
The interventions under investigation include: Steroid Therapy (DRUG), Radiation Therapy (PROCEDURE), Laser Interstitial Thermal Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT05124912?
This trial is sponsored by Monteris Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05124912 being conducted?
This trial has 9 study locations across California, Illinois, Maryland, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
RECRUITING · NA
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
RECRUITING · NA
-
Development of MRF for Characterization of Brain Tumors After Radiotherapy
RECRUITING · NA
-
MeDex: No Perioperative Dexamethasone in Brain Metastases
RECRUITING · NA
-
A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.